4,4'-(Hydroxymethylene)dibenzonitrile - CAS 134521-16-7
Catalog: |
BB007952 |
Product Name: |
4,4'-(Hydroxymethylene)dibenzonitrile |
CAS: |
134521-16-7 |
Synonyms: |
Bis(4-cyanophenyl)methanol; 4,4'-Dicyanobenzhydrol |
IUPAC Name: | 4-[(4-cyanophenyl)-hydroxymethyl]benzonitrile |
Description: | A metabolite of Letrozole. |
Molecular Weight: | 234.25 |
Molecular Formula: | C15H10N2O |
Canonical SMILES: | C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)O |
InChI: | InChI=1S/C15H10N2O/c16-9-11-1-5-13(6-2-11)15(18)14-7-3-12(10-17)4-8-14/h1-8,15,18H |
InChI Key: | JNJWXPZHWUOYRZ-UHFFFAOYSA-N |
Boiling Point: | 473.5 °C at 760 mmHg |
Melting Point: | 154-157 °C |
Purity: | 92 % |
Density: | 1.27 g/cm3 |
Appearance: | Light brown solid |
Storage: | Sealed in dry, Room Temperature |
LogP: | 2.51166 |
Publication Number | Title | Priority Date |
AU-2015273578-A1 | Small molecule LFA-1 inhibitors | 20140612 |
AU-2015273578-B2 | Small molecule LFA-1 inhibitors | 20140612 |
CA-2949934-A1 | Small molecule lfa-1 inhibitors | 20140612 |
CN-106470973-A | Small molecule LFA 1 inhibitor | 20140612 |
EP-3154941-A1 | Small molecule lfa-1 inhibitors | 20140612 |
PMID | Publication Date | Title | Journal |
23965986 | 20131101 | The letrozole phase 1 metabolite carbinol as a novel probe drug for UGT2B7 | Drug metabolism and disposition: the biological fate of chemicals |
22367241 | 20120401 | Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS | Analytical and bioanalytical chemistry |
19845430 | 20091101 | Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes | Xenobiotica; the fate of foreign compounds in biological systems |
19198839 | 20091001 | Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4'-methanol-bisbenzonitrile in vitro | Cancer chemotherapy and pharmacology |
19609393 | 20080813 | Micellar electrokinetic chromatographic study of the separation of an aromatase inhibitor and a tryciclic antidepressant in the breast cancer treatment | Analytical chemistry insights |
Complexity: | 322 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 234.079312947 |
Formal Charge: | 0 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 234.079312947 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 67.8 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.2 |
-
Catalog: BB040898
(+)-Taddol
Detail
-
Catalog: BB020676
(±)-1,2,4-Butanetriol
Detail
-
Catalog: BB080017
(1-Benzylpyrrolidine-2,5-diyl)dimethanol
Detail
-
Catalog: BB078849
((2S,4S)-1-benzyl-4-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-yl)methanol
Detail
-
Catalog: BB026447
(±)-3-Benzyloxy-1,2-propanediol
Detail
-
Catalog: BB052021
(1-Cyclopentyl-1H-pyrazol-5-yl)methanol
Detail
-
Catalog: BB043409
(+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS